Copyright
©The Author(s) 2021.
World J Clin Cases. Mar 16, 2021; 9(8): 1803-1813
Published online Mar 16, 2021. doi: 10.12998/wjcc.v9.i8.1803
Published online Mar 16, 2021. doi: 10.12998/wjcc.v9.i8.1803
Table 1 Baseline clinical characteristics of patients with common bile duct stones
Before matching, n = 257 | After matching, n = 184 | ||||||
Large CBD, n = 146 | Small CBD, n = 111 | P value | Large CBD, n = 92 | Small CBD, n = 92 | P value | ||
Gender | Male | 57 | 50 | 0.333 | 34 | 37 | 0.650 |
Female | 89 | 61 | 58 | 55 | |||
Age in yr | 60.2 ± 14.6 | 57.6 ± 12.4 | 0.138 | 59.3 ± 15.3 | 57.7 ± 12.1 | 0.443 | |
TBil in μmol/L | 13.6 (1.6-34.02) | 15.6 (4.1-33.7) | 0.227 | 12.7 (2.1-34.02) | 13.5 (4.15-33.7) | 0.39 | |
ALT in U/L | 48.5 (7-609) | 43 (6-626) | 0.364 | 33 (7-609) | 51 (6-626) | 0.152 | |
AST in U/L | 30 (10-881) | 23 (10-308) | 0.012 | 26 (10-486) | 24 (10-308.8) | 0.729 | |
GTP in U/L | 265 (11-2135) | 171 (10-1539) | 0.037 | 101 (11-1240) | 186.5 (10-1539) | 0.076 | |
Number of stone | Single | 52 | 40 | 0.945 | 34 | 32 | 0.759 |
Multiple | 94 | 71 | 58 | 60 | |||
Diameter of stones in cm | 1.0 (0.3-3.0) | 0.6 (0.2-2.0) | 0.000 | 1.0 (0.3-2.5) | 0.6 (0.2-1.7) | 0.000 | |
Hypertension | No | 116 | 77 | 0.064 | 72 | 67 | 0.391 |
Yes | 30 | 34 | 20 | 25 | |||
Diabetes | No | 132 | 97 | 0.441 | 83 | 82 | 0.809 |
Yes | 14 | 14 | 9 | 10 | |||
Heart disease | No | 134 | 102 | 0.974 | 85 | 83 | 0.601 |
Yes | 12 | 9 | 7 | 9 | |||
Pulmonary disease | No | 144 | 107 | 0.449 | 90 | 90 | 1.000 |
Yes | 2 | 4 | 2 | 2 | |||
Cerebrovascular disease | No | 142 | 108 | 1.000 | 90 | 90 | 1.000 |
Yes | 4 | 3 | 2 | 2 |
Table 2 Safety profile and procedure-related short-term outcomes of the small common bile duct and large common bile duct groups
Before matching, n = 257 | After matching, n = 184 | ||||||
Large CBD, n = 146 | Small CBD, n = 111 | P value | Large CBD, n = 92 | Small CBD, n = 92 | P value | ||
Operating time in min | 115.7 ± 32.0 | 107.2 ± 28.3 | 0.379 | 114.7 ± 33.7 | 106.4 ± 27.7 | 0.073 | |
Intraoperative blood loss in mL | 20 (5-200) | 20 (5-200) | 0.028 | 20 (5-200) | 20 (5-200) | 0.168 | |
Convert to laparotomy | No | 145 | 111 | 1.000 | 92 | 92 | |
Yes | 1 | 0 | 0 | 0 | |||
Successful stone clearance | No | 2 | 4 | 0.449 | 2 | 2 | 1.000 |
Yes | 144 | 107 | 90 | 90 | |||
Bile leakage | No | 137 | 105 | 0.797 | 85 | 88 | 0.351 |
Yes | 9 | 6 | 7 | 4 | |||
Bleeding | No | 145 | 111 | 1.000 | 91 | 92 | 1.000 |
Yes | 1 | 0 | 1 | 0 | |||
Abdominal infection | No | 138 | 106 | 0.724 | 85 | 88 | 0.351 |
Yes | 8 | 5 | 7 | 4 | |||
Pneumonia | No | 138 | 110 | 0.102 | 86 | 91 | 0.123 |
Yes | 8 | 1 | 6 | 1 | |||
Incision infection | No | 140 | 110 | 0.239 | 88 | 92 | 0.129 |
Yes | 6 | 1 | 4 | 0 | |||
Postoperative hospital stay in d | 7.7 ± 2.7 | 7.4 ± 3.6 | 0.406 | 7.7 ± 2.7 | 7.3 ± 3.7 | 0.392 |
Table 3 Procedure-related long-term outcomes of the small common bile duct and large common bile duct groups
Before matching, n = 257 | After matching, n = 184 | ||||||
Large CBD, n = 146 | Small CBD, n = 111 | P value | Large CBD, n = 92 | Small CBD, n = 92 | P value | ||
Choledochal Stenosis | No | 146 | 111 | 92 | 92 | ||
Yes | 0 | 0 | 0 | 0 | |||
Stone Recurrence | No | 136 | 109 | 0.057 | 86 | 90 | 0.278 |
Yes | 10 | 2 | 6 | 2 |
- Citation: Huang XX, Wu JY, Bai YN, Wu JY, Lv JH, Chen WZ, Huang LM, Huang RF, Yan ML. Outcomes of laparoscopic bile duct exploration for choledocholithiasis with small common bile duct. World J Clin Cases 2021; 9(8): 1803-1813
- URL: https://www.wjgnet.com/2307-8960/full/v9/i8/1803.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i8.1803